| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.046 | 0.4 |